Published in Nephrol Ther on March 25, 2010
Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med (2009) 1.76
Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes. Am J Cardiol (2010) 1.51
Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Am J Transplant (2004) 0.98
Systemic anticoagulation and prevention of hemodialysis catheter malfunction. ASAIO J (2005) 0.97
Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT). BMC Nephrol (2013) 0.93
A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med (2003) 0.93
Impact of hemocontrol on hypertension, nursing interventions, and quality of life: a randomized, controlled trial. Clin J Am Soc Nephrol (2007) 0.91
Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends. BMC Nephrol (2013) 0.88
Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort. Nephrol Dial Transplant (2013) 0.87
Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. Diabetes Res Clin Pract (2013) 0.86
The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection. Circ Res (2011) 0.86
Alteration of the platelet transcriptome in chronic kidney disease. Thromb Haemost (2012) 0.83
Carbamazepine poisoning treated by multiple extracorporeal treatments. Clin Nephrol (2015) 0.82
Measurement of blood volume during hemodialysis is a useful tool to achieve safely adequate dry weight by enhanced ultrafiltration. ASAIO J (2004) 0.82
Biofeedback regulation of ultrafiltration and dialysate conductivity for the prevention of hypotension during hemodialysis. ASAIO J (2002) 0.82
Uraemic plasma decreases the expression of ABCA1, ABCG1 and cell-cycle genes in human coronary arterial endothelial cells. Nephrol Dial Transplant (2006) 0.81
Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care. Clin J Am Soc Nephrol (2014) 0.81
Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients. Nephrol Dial Transplant (2002) 0.80
Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease. J Nephrol (2010) 0.79
[Candidemia and granulomatous tubulointerstitial nephritis]. Nephrol Ther (2008) 0.78
Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients. Am J Kidney Dis (2006) 0.78
Measurement of the international normalized ratio (INR) in hemodialysis patients with heparin-locked central venous catheters: evaluation of a novel blood sampling method. J Vasc Access (2009) 0.77
Soluble Fas: a novel predictor of atherosclerosis in dialysis patients. Am J Kidney Dis (2003) 0.77
Inadequate treatment of congestive heart failure in dialysis patients. Semin Dial (2007) 0.76
The effect of sodium citrate 4% locking solution for central venous dialysis catheter on the international normalized ratio (INR) value. Nephrol Dial Transplant (2008) 0.75
Plasmapheresis in myeloma cast nephropathy. Clin Nephrol (2013) 0.75
Heart rate dependent and independent effects of beta-blockers on central hemodynamic parameters: a propensity score analysis. J Hypertens (2016) 0.75
Gene polymorphisms as clinical tools in chronic glomerulopathies: a prospective study. Nephron Clin Pract (2013) 0.75
Uric acid association with pulsatile and steady components of central and peripheral blood pressures. J Hypertens (2017) 0.75
Enhanced development of caspase-independent cortical cell death during cold storage in kidneys of non-heart-beating donors. Transplantation (2002) 0.75